Authid Inc. current report, 28 September 2017

Business Context and Reporting Period

This Form 8-K filing by Ipsidy Inc. (referred to as Authid Inc. in metadata) reports on the Annual Meeting of Stockholders held on September 28, 2017, in Long Beach, New York. The filing details the outcomes of shareholder votes and amendments to the company's Certificate of Incorporation.

Key Financial Metrics

The filing text does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance actions and capital structure changes.

Material Changes and Corporate Actions

  • Shareholder Participation: Of 336,565,097 shares outstanding on the record date, 281,040,309 shares were represented at the meeting, constituting a quorum.
  • Board Elections: Five directors were elected to the board, including Philip D. Beck, Herbert Selzer, Ricky Solomon, Theodore Stern, and Thomas Szoke.
  • Auditor Ratification: Shareholders ratified the appointment of Cherry Bekaert LLP as independent auditors for the fiscal year ending December 31, 2017.
  • Stock Plan Approval: The 2017 Incentive Stock Plan was approved, authorizing the issuance of 70,000,000 shares of Common Stock.
  • Authorized Share Increase: The number of authorized common shares was increased from 500,000,000 to 1,000,000,000.
  • Reverse Stock Split Authorization: Shareholders approved an amendment allowing the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25 at its discretion before December 31, 2018, without further shareholder approval.

Guidance, Outlook, and Risks

The filing does not contain management commentary on future financial guidance, outlook, or specific risk factors. The primary contingency noted is the Board's newly granted discretion to execute a reverse stock split within a defined range and timeframe.

Investor Verification Checklist

  • Verify the exact reverse stock split ratio and execution date, as the Board retains discretion to set the ratio between 1-for-2 and 1-for-25.
  • Confirm the impact of the 70,000,000 new shares authorized under the Incentive Stock Plan on existing shareholder dilution.
  • Review the full Proxy Statement referenced in the filing for detailed biographies of the newly elected directors and the rationale for the stock plan.
  • Monitor future filings for the actual implementation of the reverse stock split prior to the December 31, 2018 deadline.